SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending as investors digest record financial results, highlighted by a significant year-over-year revenue surge and an accelerated path toward profitability that has energized long-term shareholders. Community discussion is currently dominated by debates over the company's valuation, the impact of historical share dilution, and the potential for a short squeeze as institutional interest grows alongside the expanding backlog of defense and drone infrastructure contracts.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying following a strategic supply agreement with Lumilens, which includes an initial order and a long-term commercial roadmap valued at over $500 million. Investors are actively discussing the company's ability to scale manufacturing for AI data center infrastructure, while the stock experiences high volatility and intense community debate surrounding warrant dilution and the transition from pre-revenue status to commercial production.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is rallying as investors pile into the space sector ahead of upcoming Q1 earnings and anticipation surrounding the major NASA LTV contract award. The community is buzzing over the company's recent strategic acquisitions and revenue growth, with many holders focused on the potential for a technical squeeze driven by institutional interest.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is attracting significant attention as investors weigh recent revenue misses and satellite deployment delays against a record-high short interest and major endorsements from institutional players like BlackRock. The community remains deeply polarized, with bulls pointing to upcoming mid-June satellite launches and long-term partnerships with major carriers as primary catalysts, while bears focus on execution risks and the gap between current valuation and realized revenue.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is attracting significant community attention as investors weigh its ongoing growth and strategic partnerships with major tech platforms against a backdrop of high short interest. Market participants are closely watching the upcoming antitrust verdict involving its PriceRunner subsidiary, which many believe could serve as a major catalyst for the stock.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors digest the company's recent Q1 earnings results and updated full-year guidance, while also closely monitoring progress on the commercial rollout of DefenCath and anticipation for clinical data on Rezzayo. Community discussion is focused on the impact of management's profitability turnaround, the effectiveness of ongoing share buyback efforts, and the potential for long-term growth as the company navigates reimbursement dynamics.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance Corp. ($PSKY) is currently a major focal point as investors closely watch the Warner Bros. Discovery ($WBD) merger process, with the community actively debating the company's valuation, potential shareholder dilution, and the long-term impact of its debt load. Investors are expressing significant frustration over recent price volatility and perceived lack of transparency, while balancing skepticism toward executive compensation against high hopes for the company's future as an AI-integrated media powerhouse.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining significant market attention as investors track the final milestones of its Phase 3 REGAL trial, with the community actively speculating on a potential short squeeze driven by heavy volume and high institutional interest. Sentiment is largely bullish, as shareholders highlight the drug's potential as a paradigm shift in oncology and view the impending data readout as a major catalyst for a valuation rerating.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is currently trending as shareholders react to the introduction of daily dividend payments on its Variable Rate Series A Perpetual Preferred Stock, alongside a shift in the company's bitcoin treasury strategy. The community is actively debating the potential for future M&A activity and the impact of the upcoming Clarity Act on the company's valuation, while long-term investors remain focused on the potential for BTC accumulation to drive future growth.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors rally ahead of a high-profile plenary session at the AUA Annual Meeting, where the company will present extended clinical data for its lead prostate cancer asset. The community is actively discussing the potential for a significant rerating or buyout, while heightened short interest and strong volume drive speculation regarding a possible short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NYKAA.NSE : Bullish View 
 
Company Business Model: 
Nykaa is an Indian beauty, wellness, and fashion retail platform operating both online and offline. It sells beauty, personal care, skincare, hair care, and fragrances, along with fashion, apparel, accessories, and home décor products. The company follows an omnichannel approach, combining digital convenience with physical retail stores to enhance customer experience and brand trust. 
 
Technical Analysis: 
Since its listing at 336.35 in 2021, Nykaa’s stock has mostly traded below its listing price for the past three years. It reached a low of 114.25 in 2023 on the NSE. However, in the last two years, the price has shown strong recovery, gaining nearly 132 percent and currently trading around 265. This rally has shifted the structure upward, and in 2025, the stock successfully broke the previous year’s high of 230, confirming an uptrend. Looking ahead, if the momentum continues, the price may test 315 levels, which will be a key zone to determine whether it can move towards creating a new all-time high above 429. 
 
Recommendation: 
 
BUY :  Ladder buying up to 215 from the current market price 
 
TARGETS:  315 – 395 – 430 – Open 
 
STOP:  200 (on weekly closing basis) 
 
DURATION:  3 to 6 months for short-term targets and 15+ months for a potential new high 
 
Challenges &amp; Risks: 
The beauty and fashion sector is highly competitive, and heavy spending on marketing and discounts can impact profitability. As a discretionary business, demand may weaken during economic slowdowns. With valuations already high, any decline in growth, execution inefficiencies, or margin pressures could create valuation risk. 
 
What to Watch: 
Margin expansion remains a key driver. If Nykaa continues to improve its operating and EBITDA margins, the current valuation premium could be justified. Growth in non-beauty verticals such as fashion and home products can provide diversification and reduce dependency on the core beauty segment. Close monitoring of advertising and logistics costs is also essential, particularly in an inflationary environment. 
 
#Warning: Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. 
 
#Disclaimer: Registration by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. 
 
#Disclosure :  
https://holdwithpriyank.com/disclosure

Yash Pathak

Ashutosh S

Bala Yogesh

Stocktwits India

Anubhav Mishra

Rajni Murugan

Curious Trader

Rahul D Dhotre

Anil Kumar

Kali Doss

Nischay

k chandra mohan

Manjunath.R

Learn to speed up your journey toward financial independence and consistently excel in changing market environments.

Holdwithpriyank

Hold With Priyank

@holdwithPriyank with a detailed look at   $NYKAA.NSE 👀

StockTwits Web

FSN E-Commerce Ventures Ltd.

 : Bullish View 
 
Company Business Model: 
Nykaa is an Indian beauty, wellness, and fashion retail platform operating both online and offline. It sells beauty, personal care, skincare, hair care, and fragrances, along with fashion, apparel, accessories, and home décor products. The company follows an omnichannel approach, combining digital convenience with physical retail stores to enhance customer experience and brand trust. 
 
Technical Analysis: 
Since its listing at 336.35 in 2021, Nykaa’s stock has mostly traded below its listing price for the past three years. It reached a low of 114.25 in 2023 on the NSE. However, in the last two years, the price has shown strong recovery, gaining nearly 132 percent and currently trading around 265. This rally has shifted the structure upward, and in 2025, the stock successfully broke the previous year’s high of 230, confirming an uptrend. Looking ahead, if the momentum continues, the price may test 315 levels, which will be a key zone to determine whether it can move towards creating a new all-time high above 429. 
 
Recommendation: 
 
BUY :  Ladder buying up to 215 from the current market price 
 
TARGETS:  315 – 395 – 430 – Open 
 
STOP:  200 (on weekly closing basis) 
 
DURATION:  3 to 6 months for short-term targets and 15+ months for a potential new high 
 
Challenges & Risks: 
The beauty and fashion sector is highly competitive, and heavy spending on marketing and discounts can impact profitability. As a discretionary business, demand may weaken during economic slowdowns. With valuations already high, any decline in growth, execution inefficiencies, or margin pressures could create valuation risk. 
 
What to Watch: 
Margin expansion remains a key driver. If Nykaa continues to improve its operating and EBITDA margins, the current valuation premium could be justified. Growth in non-beauty verticals such as fashion and home products can provide diversification and reduce dependency on the core beauty segment. Close monitoring of advertising and logistics costs is also essential, particularly in an inflationary environment. 
 


: Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. 
 


: Registration by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. 
 


This account has been verified as a SEBI Research Analyst (RA).